Shantell Laketa Heiber

Array ( [id] => 4141907 [patent_doc_number] => 06063425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Method for optimizing the efficacy of chlorous acid disinfecting sprays for poultry and other meats' [patent_app_type] => 1 [patent_app_number] => 8/948628 [patent_app_country] => US [patent_app_date] => 1997-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063425.pdf [firstpage_image] =>[orig_patent_app_number] => 948628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126140 [patent_doc_number] => 06033700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Demineralization of milk and milk-derived products by electrodeionization' [patent_app_type] => 1 [patent_app_number] => 8/946848 [patent_app_country] => US [patent_app_date] => 1997-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3591 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033700.pdf [firstpage_image] =>[orig_patent_app_number] => 946848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404369 [patent_doc_number] => 06228368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Papilloma virus capsomere formulations and method of use' [patent_app_type] => 1 [patent_app_number] => 8/944368 [patent_app_country] => US [patent_app_date] => 1997-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7623 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228368.pdf [firstpage_image] =>[orig_patent_app_number] => 944368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995600 [patent_doc_number] => 05922588 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Synthetic HPV16 virus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/943583 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6144 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922588.pdf [firstpage_image] =>[orig_patent_app_number] => 943583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096615 [patent_doc_number] => 06066324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/817335 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4372 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066324.pdf [firstpage_image] =>[orig_patent_app_number] => 817335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920712 [patent_doc_number] => 05914113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Inactivated vaccines' [patent_app_type] => 1 [patent_app_number] => 8/939046 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3823 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914113.pdf [firstpage_image] =>[orig_patent_app_number] => 939046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067861 [patent_doc_number] => 05965134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Immunogenic composition against Classical Swine Fever Virus (CSFV)' [patent_app_type] => 1 [patent_app_number] => 8/937102 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14304 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965134.pdf [firstpage_image] =>[orig_patent_app_number] => 937102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024400 [patent_doc_number] => 05925734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II .beta.chains' [patent_app_type] => 1 [patent_app_number] => 8/936854 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 16508 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925734.pdf [firstpage_image] =>[orig_patent_app_number] => 936854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998363 [patent_doc_number] => 06004557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Variants of human papillomavirus antigens' [patent_app_type] => 1 [patent_app_number] => 8/860165 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10181 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004557.pdf [firstpage_image] =>[orig_patent_app_number] => 860165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049718 [patent_doc_number] => 05932412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes' [patent_app_type] => 1 [patent_app_number] => 8/934915 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 22506 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932412.pdf [firstpage_image] =>[orig_patent_app_number] => 934915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413899 [patent_doc_number] => 06193980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Replication defective herpes simplex virus comprising heterologous inserts' [patent_app_type] => 1 [patent_app_number] => 8/875225 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9523 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193980.pdf [firstpage_image] =>[orig_patent_app_number] => 875225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209548 [patent_doc_number] => 06110468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Vaccine for swine infertility and respiratory syndrome and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/927786 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 12770 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110468.pdf [firstpage_image] =>[orig_patent_app_number] => 927786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237212 [patent_doc_number] => 06080570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Method of producing a vaccine for Swine Infertility and Respiratory Syndrome' [patent_app_type] => 1 [patent_app_number] => 8/927052 [patent_app_country] => US [patent_app_date] => 1997-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12763 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080570.pdf [firstpage_image] =>[orig_patent_app_number] => 927052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4417001 [patent_doc_number] => 06224878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Mutants and vaccines of the infectious bovine rhinotracheitis virus' [patent_app_type] => 1 [patent_app_number] => 8/924345 [patent_app_country] => US [patent_app_date] => 1997-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 8358 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/224/06224878.pdf [firstpage_image] =>[orig_patent_app_number] => 924345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379670 [patent_doc_number] => 06261807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Method for preparing a recombinant adenovirus genome' [patent_app_type] => 1 [patent_app_number] => 8/894014 [patent_app_country] => US [patent_app_date] => 1997-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7174 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261807.pdf [firstpage_image] =>[orig_patent_app_number] => 894014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081556 [patent_doc_number] => 06017541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Immunogens for the production of cocaine-hydrolyzing catalytic antibodies' [patent_app_type] => 1 [patent_app_number] => 8/906151 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 5807 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017541.pdf [firstpage_image] =>[orig_patent_app_number] => 906151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236138 [patent_doc_number] => 06090609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Crystallized N-terminal domain of influenza virus matrix protein M1 and method of determining and using same' [patent_app_type] => 1 [patent_app_number] => 8/904489 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55580 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090609.pdf [firstpage_image] =>[orig_patent_app_number] => 904489 [rel_patent_id] =>[rel_patent_doc_number] =>)